Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

187.64
BATS BZX Real-Time Price
As of 3:46pm ET
 -1.50 / -0.80%
Today’s Change
161.09
Today|||52-Week Range
209.22
+10.13%
Year-to-Date
Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug
3:51am / Zacks.com - Paid Partner Content
Shire Stock Rises Premarket on Positive Phase 3 Results for Angiodema Treatment
May 18 / TheStreet.com - Paid Partner Content
Company News for May 19, 2017
May 19 / Zacks.com - Paid Partner Content
Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status
May 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
New South Capital Management Inc Buys Shire PLC, Travelport Worldwide, Brookdale Seni...
May 16 / GuruFocus News - Paid Partner Content
Biotech Movers: Fast Track Designation Sends Sage Shares Higher
May 18 / TheStreet.com - Paid Partner Content
Larry Robbins Buys Dow Chemical Co, Intel Corp, Shire PLC, Sells Healthsouth Corp, HC...
May 15 / GuruFocus News - Paid Partner Content
Checking Out the Pre-Market Action
May 18 / TheStreet.com - Paid Partner Content
Julian Robertson Buys Adobe and Sells Apple in 1st Quarter
May 15 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close189.14
Today’s open190.56
Day’s range187.50 - 190.56
Volume53,208
Average volume (3 months)1,027,187
Market cap$57.2B
Dividend yield0.48%
Data as of 3:46pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+15.37%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+76.71%
P/E ratio133.1
Price/Sales3.89
Price/Book1.95

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...+11.29+2.51%
AGNAllergan+0.52+0.24%
ABTAbbott Laboratories+0.62+1.44%
NVONovo Nordisk+0.66+1.62%
Data as of 3:48pm ET, 05/22/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$3.59
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts